Use of antigenic substances for the prophylaxis or therapy...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/129

A61K 39/00 (2006.01)

Patent

CA 1325592

A B S T R A C T USE OF ANTIGENIC SUBSTANCES FOR THE PROPHYLAXIS OF TREATMENT OF DISORDERS OR DISEASES WITH THE GASTROINTESTINAL TRACT Of ANIMALS AND HUMANS The invention refers to the use of antigenic substances for the prohylaxis or therapy of disorders and diseases with the gastrointestinal tract of animals and humans. Disorders and diseases with the gastrointestinal tract of animals and humans, for instance, diarrhea, peptic ulcers diseases or cancer represent a worldwide serious, economically significant problem. It could be shown that the immunological mechanisms have a protective effect in the gastrointestinal tract of animals and humans. Antigens being present in the food induce the above-mentioned protective mechanisms when the organism has already been immunized with these antigens. A preferred use of antigenic substances is for the prophylaxis and therapy of peptic ulcer diseases in humans. Furthermore, these antigenic substances are especially suitable for the breeding of young cattle when the food is changed within the first weeks of life.

564305

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of antigenic substances for the prophylaxis or therapy... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of antigenic substances for the prophylaxis or therapy..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of antigenic substances for the prophylaxis or therapy... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1268692

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.